Pharmacological approaches to avoid bacterial resistance development

Abstract

This issue of antibiotic resistance has long been overlooked by the public, medical professionals and pharmaceutical companies. In this paper I stress the need for international collaboration, which is mainly mediated by European Centre for Disease Prevention and Control and World Health Organization, causes of resistance, simple methods to prevent further resistance, alternative therapies and novel pharmacological targets that could potentially prevent us from entering a post-antibiotic era.